Back

Epithelia mediate inflammation with myeloid cells in Crohn's disease patients under treatment

Zhou, R.; Xie, B.; Liu, J.; Zhao, Y.; Koval, J.; Cham, C.; Pekow, J.; Weber, C.; Chang, E.; Basu, A.

2025-03-31 immunology
10.1101/2025.03.26.645552 bioRxiv
Show abstract

Crohns disease (CD), a major class of Inflammatory Bowel Disease (IBD), is a chronic condition affecting millions, with >50% of the patients experiencing relapses marked by inflammation. Our cellular atlas (380,000 cells) of the terminal ileum (TI) and ascending colon (AC) mucosa from 46 CD and non-IBD donors across various clinical condition, decipher disease heterogeneity for CD relapse and refractory inflammation. We identified an inflammatory cascade mediated by follicle-associated enterocytes in the inflamed TI involving pro-inflammatory macrophage M1 that remained unresolved by given biologic treatments. Spatial transcriptomic validation confirmed this epithelial-immune crosstalk. In contrast, interactions between colonocytes, FAP+ stroma and innate immune cells were were the unresolved cascade in AC driving inflammation. In addition, we propose a transcript-based scoring method to quantify inflammation activity that can be used to compare inflammation levels across patients, with the overall aim to help disease stratification.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.